Amir H. Kalali, MD
- 5Articles
- 13KReads
- 2004–2010Active
- 15Collaborators
- 3Citations
About
Amir H. Kalali, MD, has authored multiple articles published between 2004 and 2010 focusing on the treatment of bipolar disorder, anxiety, and schizophrenia/schizoaffective disorders. His work includes clinical trials evaluating extended-release carbamazepine capsules as monotherapy for acute mania and mixed episodes in bipolar disorder. Kalali has also contributed to discussions on the development of new medications for schizophrenia and conceptual considerations in assessing treatment onset in depression and anxiety.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
